The emerging approach of the medication represents a significant development in the care of type 2 diabetes. Unlike existing therapies, tirzepatide targets multiple pathways – GLP-1 and glucose-dependent https://tirzepatide-peptide422509.losblogos.com/40697802/tirzepatide-peptide-a-new-frontier-in-diabetes-treatment